Developing a trace level GC-MS method for detecting methylhydrazine in an experimental drug substance

Area of Science:

• Analytical Chemistry
• Pharmaceutical Analysis

Background:

• Methylhydrazine (CAS 60-34-4) is a reactive reducing agent and chemical intermediate.
• It is a known mutagen, animal carcinogen, and suspected human carcinogen, necessitating strict control in pharmaceutical synthesis.

Purpose of the Study:

• To develop a sensitive analytical method for detecting trace levels of methylhydrazine in an experimental drug substance.
• To establish a limit test method for ensuring the safety and purity of the drug substance.

Main Methods:

• Gas chromatography-mass spectrometry (GC-MS) was employed for methylhydrazine analysis.
• Acetone served as both a solvent for the drug substance and a derivatizing agent for methylhydrazine, simplifying sample preparation.
• Direct injection GC with selected ion monitoring (SIM) at m/z 86 was used for detection.

Main Results:

• The developed method effectively separated the acetone-methylhydrazine derivative (acetone methylhydrazone) from matrix interferences.
• Mass spectrometric detection in SIM mode achieved a sensitivity of 1 part per million (ppm) for methylhydrazine relative to the drug substance.
• The method eliminated the need for post-derivatization sample clean-up.

Conclusions:

• A validated GC-MS method allows for the accurate and sensitive quantification of trace methylhydrazine in experimental drug substances.
• This analytical approach is crucial for quality control and safety assessment of pharmaceuticals containing methylhydrazine as an intermediate.